Boenning & Scattergood Starts Regeneron Pharma (REGN) at Outperform; Share Price Volatility Likely to Create Buying Opportunity for L-T Investors

Go back to Boenning & Scattergood Starts Regeneron Pharma (REGN) at Outperform; Share Price Volatility Likely to Create Buying Opportunity for L-T Investors